Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models

Epilepsy Research

Volumn 15, Issue 3, 1993, Pages 179-184

  Yamaguchi, Shun ichi ^a   Donevan, Sean D ^a   Rogawski, Michael A ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Anticonvulsant drugs; Competitive and non competitive non NMDA antagonists; Experimental seizures

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 4 AMINOPYRIDINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRIC SHOCK; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

4-AMINOPYRIDINE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMAL; ANTICONVULSANTS; BENZODIAZEPINES; BINDING, COMPETITIVE; COMPARATIVE STUDY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; HINDLIMB; KAINIC ACID; MALE; MICE; PENTYLENETETRAZOLE; QUINOXALINES; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; SEIZURES;

EID: 0027242080     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-1211(93)90054-B     Document Type: Article

References (22)

1. Excitatory amino acid antagonists and therapy of epilepsy
2. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice
3. Excitatory amino acid receptors in the vertebrate central nervous system
4. A new device for the rapid measurement of impaired motor function in mice
5. Quinoxalinediones as excitatory amino acid antagonists in the vertebrate central nervous system
6. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonists of AMPA/kainate receptor responses
7. The epileptiform activity induced by 4-aminopyridine in rat amygdala slices: antagonism by non-N-methyl-d-aspartate receptor antagonists
8. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists
9. The involvement of excitatory amino acids in neocortical epileptogenesis: NMDA and non-NMDA receptors
10. N-methyl-d-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs
11. GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones
12. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds
13. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline: a neuroprotectant for cerebral ischemia
14. The non-N-methyl-d-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy
15. General principles. Experimental selection, quantification, and evaluation of anticonvulsants
16. Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466
17. GYKI 52466, an inhibitor of spinal reflexes is a potent quisqualate antagonist
18. Probenecid pretreatment enhances anticonvulsant action of NBQX in mice
19. Relief of experimental spasticity and anxioiytic/anticonvulsant actions of the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-enzo[f]quinoxaline
20. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice
21. A benzodiazepine recognition site associated with the non-NMDA glutamate receptor